Liau et al. J Transl Med (2018) 16:179 https://doi.org/10.1186/s12967-018-1552-1 CORRECTION Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Linda M. Liau 1* , Keyoumars Ashkan 2 , David D. Tran 3 , Jian L. Campian 4 , John E. Trusheim 5 , Charles S. Cobbs 6 , Jason A. Heth 7 , Michael Salacz 8 , Sarah Taylor 8 , Stacy D. D’Andre 9 , Fabio M. Iwamoto 10 , Edward J. Dropcho 11 , Yaron A. Moshel 12 , Kevin A. Walter 13 , Clement P. Pillainayagam 14 , Robert Aiken 15 , Rekha Chaudhary 16 , Samuel A. Goldlust 17 , Daniela A. Bota 18 , Paul Duic 19 , Jai Grewal 59 , Heinrich Elinzano 20 , Steven A. Toms 20 , Kevin O. Lillehei 21 , Tom Mikkelsen 22 , Tobias Walbert 22 , Steven R. Abram 23 , Andrew J. Brenner 24 , Steven Brem 25 , Matthew G. Ewend 26 , Simon Khagi 26 , Jana Portnow 27 , Lyndon J. Kim 28 , William G. Loudon 29 , Reid C. Thompson 30 , David E. Avigan 31 , Karen L. Fink 32 , Francois J. Geoffroy 33 , Scott Lindhorst 34 , Jose Lutzky 35 , Andrew E. Sloan 36 , Gabriele Schackert 37 , Dietmar Krex 37 , Hans-Jorg Meisel 38 , Julian Wu 39 , Raphael P. Davis 40 , Christopher Duma 41 , Arnold B. Etame 42 , David Mathieu 43 , Santosh Kesari 44 , David Piccioni 44 , Manfred Westphal 45 , David S. Baskin 46 , Pamela Z. New 46 , Michel Lacroix 47 , Sven-Axel May 48 , Timothy J. Pluard 49 , Victor Tse 50 , Richard M. Green 51 , John L. Villano 52 , Michael Pearlman 53 , Kevin Petrecca 54 , Michael Schulder 55 , Lynne P. Taylor 56 , Anthony E. Maida 58 , Robert M. Prins 1 , Timothy F. Cloughesy 1 , Paul Mulholland 57 and Marnix L. Bosch 58* © The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Correction to: J Transl Med (2018) 16:142 https://doi.org/10.1186/s12967-018-1507-6 Following publication of the original article [1], the authors reported an error in the spelling of one of the author names. In this Correction the incorrect and cor- rect author names are indicated and the author name has been updated in the original publication. Te authors also reported an error in the Methods section of the original article. In this Correction the incorrect and correct versions of the afected sentence are indi- cated. Te original article has not been updated with regards to the error in the Methods section. Incorrect author name upon publication: • Tobias Walpert Te correct author name: • Tobias Walbert Te afected sentence in the Methods section upon publication, with the error marked in bold: • In general, approximately 2 g of tumor tissue was needed to produce the full ten doses for the 36-month treatment and follow-up schedule. Te vaccine was aliquoted in individual doses and cryo- preserved at < 150 °C [22]. Te corrected sentence, with the corrected tempera- ture marked in bold: Open Access Journal of Translational Medicine *Correspondence: lliau@mednet.ucla.edu; marnix@nwbio.com 1 University of California Los Angeles (UCLA) David Geffen School of Medicine & Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA 58 Northwest Biotherapeutics Inc., Bethesda, MD, USA Full list of author information is available at the end of the article